Switching of biologics in psoriasis: Reasons and results-Reference-Cited by-同舟云学术

Switching of biologics in psoriasis: Reasons and results

Published:2017-05-10 Issue:9 Volume:44 Page:1015-1019
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Honda Hiromi¹^ORCID,Umezawa Yoshinori¹,Kikuchi Sota¹,Yanaba Koichi¹^ORCID,Fukuchi Osamu¹,Ito Toshihiro¹,Nobeyama Yoshimasa¹^ORCID,Asahina Akihiko¹^ORCID,Nakagawa Hidemi¹

Affiliation:

1. Department of Dermatology; The Jikei University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13860/fullpdf

Reference25 articles.

1. Psoriasis;Schon;N Engl J Med,2005

2. Japanese Infliximab Study i. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial;Torii;J Dermatol Sci,2010

3. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial;Gottlieb;J Am Acad Dermatol,2004

4. Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study;Asahina;J Dermatol,2010

5. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial;Menter;J Am Acad Dermatol,2008

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13‐year retrospective study;The Journal of Dermatology;2024-09-13

2. Sequential interleukin-17 inhibitors for moderate-to-severe plaque psoriasis who have an IL-17 inhibitors failure in a resource limited country: An economic evaluation;PLOS ONE;2024-08-09

3. Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry;Drugs - Real World Outcomes;2024-06-24

4. Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan;Journal of Dermatological Treatment;2024-02-05

5. Switching biologics in psoriasis: Challenges and experience from a small tertiary health-care center;Sanamed;2024